news
Generation Lab offers 'young blood' injectable
A startup called Generation Lab is pitching an injectable blend of two existing drugs, which they're calling '1 Generation,' claiming it can rejuvenate blood. They're offering it to 'longevity influencers' first, bypassing traditional clinical trial marketing. The goal is to make your blood 'young' again.
A startup called Generation Lab is pitching an injectable blend of two existing drugs, which they're calling '1 Generation,' claiming it can rejuvenate blood. They're offering it to 'longevity influencers' first, bypassing traditional clinical trial marketing. The goal is to make your blood 'young' again.
The architecture take
So, a company wants to inject you with a combo of existing drugs, saying it'll make your blood young. Sounds… bold. The play here isn't just about a new product; it's about side-stepping the usual clinical validation by hitting up 'longevity influencers' first. I get why they'd try to skip some red tape, but mixing existing drugs and calling it 'rejuvenation' is a big leap for a consumer-facing treatment. What this really tells me is the market for biological age reversal is white-hot, and some companies will get pretty creative with their go-to-market. It's a calculated gamble on consumer desperation for youth, but your body isn't an experiment. I'd watch for actual, peer-reviewed data on mechanism and safety, not just influencer anecdotes.